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Retentive device for intravesical drug delivery based on water-induced shape memory 
response of poly(vinyl alcohol): design concept and 4D printing feasibility 
 
Dear Prof. J. Siepmann, Ph.D. 
Editor-in-Chief of International Journal of Pharmaceutics 
 
We would like to thank the Reviewers for providing helpful comments and appreciating our 
work. Please find below a point-by-point outline of how the manuscript has been modified 
accordingly. 
 
Reviewer #2: 
General comments 
The graphical abstract should be more immediate and give a sharp message. 
We thank the Referee for the suggestion. The graphical abstract was accordingly modified to be 
simpler and provide a sharp message. 
The scope of the paper is confined to a few lines in the introduction. Please expand and anticipate 
the various steps envisaged and describe/justify the techniques /methods proposed to fulfill the 
scope. This would help understanding on behalf of a less skilled reader.  
The scope of the manuscript was expanded to include the various experimental steps/methods 
envisaged and, as requested by Reviewer #3, to justify the choice of poly(vinyl alcohol). 
The concept of shape memory polymers is not immediate and deserves to be better explained. Even 
the concept of 4D printing should be worked out and made more explicit. 
We agree with the Referee that the concepts of shape memory polymers and 4D printing would 
deserve more in-depth explanation. We have made effort in this respect, also adding related 
references. 
Overall the idea is very innovative and the paper deserves pubblication. 
 
Reviewer #3: 
The manuscript submitted by Melocchi et al. combines the use of a new technology with the 
exploration of materials properties in a potential application with high clinical impact. Overall the 
manuscript is well designed and experiments carefully performed, generating data discussed in 
detail. 
*Response to Reviewers
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However, some points should be considered as follows: 
 Abstract - the abstract does not entirely reflect the work with too many general considerations 
and less information about the work itself. An improved abstract should be considered. 
We have revised the abstract following the Referee’s suggestions, deleting too general 
considerations and adding information about the experimental work performed. 
 Keywords - are more likely key expressions and some key words are not relevant for the scope 
of the manuscript. 
We have updated the keywords avoiding key expressions that were less related to the work 
performed. 
 A list of abbreviations would help to better understand and follow the text. 
A list of the abbreviations used in the manuscript has been provided. 
 Introduction - very little justification is provided to support the choice of PVA as a key material 
for the manufacture of the matrices. 
The introduction section has been revised providing justification for the choice of poly(vinyl 
alcohol) and it was also expanded to include the various experimental steps/methods envisaged 
in the research work, as requested by Reviewer #2. 
 Materials and methods - there is no justification for the grades and only 2 grades of PVA were 
considered. Furthermore why glycerol was considered. The reviewer believes that preliminary 
work pointed out to the use of these materials, but if that was the case, authors should refer the 
fact to provide a proper background for their selection. Likewise, authors do not provide any 
justification to support the processing conditions (Table 1) for both HME and FDM, 
particularly the selection of temperature and torque. Furthermore why extrudates had to be 
pulled and forced to pass through a caliper (lines 149-150)? 
The Referee is right about the use of only 2 grades of poly(vinyl alcohol). Actually, we 
preliminarily investigated more, though processing turned out very critical for poly(vinyl 
alcohol) with higher molecular weights, thus requiring further investigation and process design 
studies. For this reason, we decided to go ahead with the grades here presented, which offered 
a good compromise between processability and softness of the polymer once hydrated, which is 
related to the expected performance of the system over time. However, we are already 
expanding our investigation including further grades of poly(vinyl alcohol), for which greater 
processing issues are being faced. 
Glycerol was selected based on the review of the scientific literature, testifying its wide use as 
plasticizer for poly(vinyl alcohol), and on experience we previously gained on hot melt 
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extrusion and fused deposition modeling of such a polymer. This was better clarified in the text, 
also including relevant literature references. 
Considering HME and FDM processes, suitable operating conditions were selected through a 
preliminary set-up relying on the expertise acquired and on a trial-and-error approach 
depending on the evaluation of the product quality in terms of aspect, homogeneity, adherence 
to previously set specifications (e.g. dimensions) and reproducibility. With regard to pulling 
and forcing extrudates to pass through a caliper, this was required in order to calibrate the 
filament diameter to counteract possible swelling phenomena of the extrudate. This in-process 
control would help in reducing the amount of final product out of the diameter specifications 
previously set, because filaments having diameter greater than 1.80 mm would be unsuitable 
for 3D printing by the equipment in use (a final control of diameter is also carried out after 
cooling). In industrial manufacturing plants, this issue is solved by the presence of a laser unit 
downline of the extruder to control the filament diameter before spooling. When portions out of 
specifications are revealed, a signal is automatically transmitted to the equipment to adjust the 
process conditions (e.g. screw and spooling speed), thus correcting the filament size. 
We agree with the referee that the above details were missing in the manuscript and that 
literature references would not be enough for the reader. Therefore, we have tried to improve 
the text accordingly. 
 Results and Discussion 
Section 3.2 does not refer the reproducibility of the systems. Can it be assumed that only 1 
sample was prepared and compared? 
We agree with the Referee that Section 3.2 does not provide information on the reproducibility 
of the system. The work performed is indeed very preliminary focusing on a novel subject and 
reports data relevant to single samples for each formulation and shape under study. This 
should now be clearer in the Methods Section after the changes introduced. Actually, based on 
our knowledge, the use of a single curve to represent a time/temperature dependent response is 
not uncommon in scientific papers on shape memory polymers belonging to fields other than 
pharmaceutics and is also related to the challenges involved in the manual programming of the 
temporary shape of the specimen in a lab setup. 
This section also fails to produce more evidence on the relationship between the materials 
properties', the processing conditions and the resultant printed materials. 
We agree with the Referee that evidence on the relationship between the material properties, 
processing conditions and performance of the resulting systems have not been exhaustively 
faced in Section 3.2. We are aware that these aspects are of utmost importance, particularly for 
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optimization and scale-up of the production processes, and we will definitely be committed to 
deepen our research to include the above-mentioned topics in the future. Although an effort 
was made to introduce changes into this Section, we would like to point out that the fine-tuning 
of its manufacturing processes was not the focus of the current work and its goal was rather to 
demonstrate the possibility of exploiting the water-induced shape memory behavior of a 
polymer of pharmaceutical grade for the development of a new drug delivery system. We hope 
that our preliminarily results may be considered as an interesting starting point 
Surprisingly, due to the authors' expertise in the area, section 3.3 is over summarized and little 
related with the previous section. Indeed the water contributes to the memory activation 
together with the temperature. Furthermore figure 7 cannot be read by itself and description of 
FU and RDM could not be found in the text. As it is, the value of this section is hard to 
recognise in the manuscripts context. An improved connection between the sections is deemed 
required for an improved understanding of the work. 
Section 3.3 was reworded in an effort to strengthen its connection with the previous one and 
highlight the relevance of fluid uptake and residual dry mass experiments for the overall 
performance of the system. Further comments to the results obtained have also been reported. 
Following Referee’s suggestion, we have tried to make Figure 7 more readable. Moreover, as 
requested by the Referee, a list of abbreviations and relevant explanation, including FU and 
RDM, has been included at the beginning of the manuscript. 
 Conclusions - overall conclusions are correct although further evidence on the relationship 
between the materials, processing conditions and products properties would have been of great 
benefit for the reader. 
As stated above in response to the comments of Reviewer #3 to section 3.2, because the goal of 
our work was necessarily limited to investigating the viability of hot-processing of 
pharmaceutical-grade poly(vinyl alcohol) having water-induced shape memory response in the 
development of a retentive intravesical delivery systems, we do not unfortunately feel like 
broadening the Conclusions, which have to be strictly related to the aim and reflect the work 
performed. 
 
Comments from the editor: 
1) Could you please indicate a little bit more clearly what you mean by "4D printing" in the 
abstract? 
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We have made an effort to clarify what is meant for 4D printing, both in the abstract, in a more 
synthetic form due to the limited word count, and more into detail in the Introduction section, 
also following the request of Reviewer #2. 
2) Could you please add scale bars to Figures 3 and 8? 
We have added scale bars to Figures 3 and 8. 
3) Figures 4 - 6: Could you please increase the size of the text and numbers (so that they are 
clearly visible, even in a print version)? 
We have increased the size of the text and numbers in Figures 4 and 6 to make them clearly 
visible. 
4) Tables 4 and 7: Could you please indicate what the lengths of the grids in the pictures are? 
We have indicated the length of the grids in the pictures reported in Tables 4 and 7. 
*Graphical Abstract (for review)
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Abstract 17 
The use of shape memory polymers exhibiting water-induced shape recovery at body temperature 18 
and water solubility was proposed for the development of indwelling devices for intravesical drug 19 
delivery. These could be administered via catheter in a suitable temporary shape, retained in the 20 
bladder for a programmed period of time by recovery of the original shape and eliminated with urine 21 
following dissolution/erosion. Hot melt extrusion and fused deposition modeling 3D printing were 22 
employed as the manufacturing techniques, the latter resulting in 4D printing because of the shape 23 
modifications undergone by the printed item over time. Pharmaceutical-grade poly(vinyl alcohol) 24 
was selected based on its hot-processability, availability in different molecular weights and on 25 
preliminary data showing water-induced shape memory behavior. Specimens having various original 26 
and temporary geometries as well as compositions, successfully obtained, were characterized by 27 
differential scanning calorimetry and dynamic-mechanical thermal analysis as well as for fluid 28 
uptake, mass loss, shape recovery and release behavior. The samples exhibited the desired ability to 29 
recover the original shape, consistent in kinetics with the relevant thermo-mechanical properties, and 30 
concomitant prolonged release of a tracer. Although preliminary in scope, this study indicated the 31 
viability of the proposed approach to the design of retentive intravesical delivery systems. 32 
 33 
Keywords: shape memory polymer; poly(vinyl alcohol); hot melt extrusion; fused deposition 34 
modeling; 3D printing; 4D printing; intravesical delivery.  35 
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List of abbreviation 36 
3D: three dimensional 37 
4D: four dimensional 38 
α: angle between the two arms of U- and I-shaped samples during recovery 39 
αp: angle obtained in the programming phase of shape recovery experiments 40 
CAD: computer-aided design 41 
CFF: caffeine 42 
DSC: differential scanning calorimetry 43 
DMTA: dynamic-mechanical thermal analysis 44 
E': storage modulus 45 
E'Troom: storage modulus at room temperature 46 
E'Tdef: storage modulus at deformation temperature 47 
FDM: fused deposition modeling 48 
FU: fluid uptake 49 
GLY: glycerol 50 
HME: hot melt extrusion 51 
Nfinal: number of windings of helical-shaped samples at the end of recovery 52 
N0: number of windings of helical-shaped samples before programming 53 
PVA: poly(vinyl alcohol) 54 
RDM: residual dry mass 55 
RI: recovery index 56 
RIfinal: final recovery index 57 
SMP: shape memory polymer 58 
Tdef: deformation temperature 59 
Tg: glass transition temperature 60 
Troom: room temperature 61 
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t10%: time needed to reach 10% of drug release 62 
t90%: time needed to reach 90% of drug release 63 
tRIfinal: time needed to reach final recovery index 64 
Wm: mass of the wet sample on withdrawal 65 
Wd: mass of the sample after drying 66 
Wi: initial mass of the sample 67 
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1. Introduction 68 
The bladder is a muscle-epithelial sac responsible for the collection of waste substances from the 69 
systemic circulation, coming from the kidneys, and their elimination as urinary fluids (GuhaSarkar, 70 
and Banerjee, 2010, Hsu et al, 2013, Zacchè et al., 2015). Considering its pivotal role in the 71 
homeostasis of the human body, any change in its functionality, even caused by the natural aging 72 
process or brought about by the onset of diseases, is necessarily associated with inconveniences of 73 
different extent. Vesical diseases, such as atonic and hyperactive bladder, interstitial cystitis and 74 
cancer, are widespread in individuals of different age and gender. However, their incidence increases 75 
in elderly people, who represent the population segment of developed countries in continuous growth 76 
and whose therapeutic treatments have great impact on healthcare expenses. The pharmacological 77 
therapy of such pathologies involves both systemic administration, mainly by the oral route, and in 78 
situ transurethral instillation of different active ingredients. Topical administration of drugs offers 79 
several advantages, e.g. to reduce the systemic side effects and avoid possible presystemic elimination 80 
mainly by the liver (first-pass effect), thus also allowing lower drug strengths to be used. Currently, 81 
solutions, suspensions or emulsions containing one or more drugs are instilled into the bladder 82 
through a catheter, inserted directly into the urethra of the patient and then clamped off for a pre-83 
determined time period (from few minutes up to at least 1 h for chemotherapy), before being drained 84 
or normally excreted after withdrawal of the catheter. In the case the latter is removed immediately 85 
after instillation and the patient is asked to keep the solution in the bladder for the longest possible 86 
time, the maximum residence time of drugs within the bladder hardly exceeds 2 h, even when fluid 87 
intake is avoided. With the aim of counteracting the drug washout, repeated instillations are thus 88 
required, and this may entail other complications, such as primarily the onset of infections. 89 
In order to maintain effective concentrations of the bioactive molecules within the bladder, various 90 
strategies have been pursued such as the use of bioadhesive liposome- or thermosensitive hydrogel-91 
based formulations (Cima et al., 2014, Farokhzad et al., 2006, Nirmal et al. 2010, Tyagi et al., 2016). 92 
One of the most innovative approaches to intravesical delivery is represented by indwelling systems 93 
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administered transurethrally via catheter, that are designed to remain in the bladder for longer time 94 
periods (e.g. weeks). This resembles the concept of expandable gastroretentive dosage forms, the 95 
original size of which is reduced, e.g. by folding, into a carrier system such as a capsule: after 96 
administration, the carrier dissolves or opens up in stomach and the unit conveyed recovers a 97 
significantly larger spatial encumbrance due to swelling or unfolding processes that prolong its gastric 98 
retention time (Klausner et al., 2003). Analogously, bladder retention was obtained through either an 99 
increase in the size of the devices (e.g. UROS, Situs Corporation) or a change in the relevant geometry 100 
after being positioned into the organ (e.g. LiRIS, TARIS Biomedical). The success of the indwelling 101 
drug delivery systems described so far is still limited due to their poor tolerability, mainly associated 102 
with relatively large dimensions, density higher than that of urine and need for a removal procedure 103 
at the end of the treatment (Lee and Choy, 2016, Lee and Cima, 2011, Nickel et al., 2012). The idea 104 
of a biodegradable indwelling system that would not involve subsequent removal was preliminarily 105 
proposed (Tobias et al., 2010). However, the mechanism of retention (e.g. based on size increase or 106 
on geometry variation) was not clearly defined. 107 
Over the last few years, shape memory polymers (SMPs) have drawn great interest in the area of 108 
advanced systems intended for biomedical applications (Behl and Lendlein, 2007, Chan et al., 2016, 109 
El Feninat et al., 2002, Lendlein and Langer, 2002, Lendlein et al., 2010, Sokolowski et al., 2007, 110 
Yahia, 2015). They belong to smart materials capable of i) memorizing a permanent/original shape, 111 
ii) being fixed, under appropriate temperature conditions and mechanical stress, to a temporary shape 112 
and iii) being triggered, by an external stimulus such as a change in temperature, light, moisture, 113 
magnetic field or electrical current, to spontaneously recover the memorized stress-free permanent 114 
shape (Liu et al., 2007; Hager et al., 2015; Huang et al., 2010). Microstructural changes of the polymer 115 
are responsible for shape fixing and shape recovery, the latter relaxation step being associated with 116 
elastic deformation stored during previous manipulation. 117 
In this respect, much attention has been focused on SMP-based devices in which shape changes could 118 
be obtained at body temperature. Once introduced into the human body, these would be able to modify 119 
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their shape thanks to exposure to 37 °C, thus performing their function. Interestingly, in a particular 120 
class of SMPs, shape modifications can be triggered not only by heating but also through contact with 121 
water (i.e. water-induced shape memory effect). Such SMPs are hydrophilic polymers for which 122 
water taken up acts as a plasticizer and reduces the temperature required to activate the shape memory 123 
response (Yang et al., 2004). In addition, SMPs characterized by water-induced shape memory 124 
behavior and suitable thermoplastic properties could be subjected to hot-processing via forming 125 
manufacturing techniques, such as hot melt extrusion (HME), injection molding and fused deposition 126 
modeling (FDM) 3D printing, which are well-known to yield high versatile geometries, details and 127 
sizes of products. Notably, the combined use of 3D printing technologies and SMPs has recently led 128 
to the new concept of 4D printing, intended as fabrication via 3D printing of items capable of self-129 
transforming after production in terms of morphology, and thus possibly of functionality, in response 130 
to an external stimulus (Ding et al., 2017, Gao et al., 2016, Lee et al., 2017; Maniruzzamann 2018). 131 
As compared with 3D printing, 4D printing involves the use of smart materials and also an advanced 132 
design, which has to take account of the original shape, the temporary shape, the transformations 133 
undergone by the object to shift from one another and relevant mechanisms. The time frame in which 134 
the original shape is recovered represents the 4th dimension. In spite of the huge potential held, major 135 
applications of 4D printing in the development of drug delivery systems are yet to come. 136 
Based on such premises, the aim of the present work was to study the possible water-induced shape 137 
memory response of specimens fabricated from poly(vinyl alcohol) (PVA) of pharmaceutical grade 138 
by means of hot-processing techniques, namely HME and FDM. In particular, PVA was chosen in 139 
view of its known suitability for hot-processing and on preliminary results pointing out its water-140 
induced shape memory behavior. Indeed, such a property could advantageously be exploited for the 141 
development of intravesical retentive systems, i.e. devices suitable for administration via catheter in 142 
the programmed/temporary shape and for bladder retention following spontaneous recovery of the 143 
permanent/original shape. Thanks to its slow interaction with aqueous fluids and related dissolution, 144 
it was deemed to hold potential as the main component of an indwelling drug delivery system for 145 
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prolonged release, with no need for being removed thanks to its erosion/dissolution over time. 146 
Moreover, the release rate could interestingly be tuned by selecting the polymer molecular weight. 147 
The feasibility of 4D printing in the manufacturing of such a device was preliminarily evaluated by 148 
characterizing the specimens obtained for thermo-mechanical properties, water-induced shape 149 
recovery, fluid uptake, mass loss as well as release behavior, using samples containing an analytical 150 
tracer. 151 
 152 
2. Materials and Methods 153 
2.1 Materials 154 
PVA of different grades (Gohsenol™ EG 05P and Gohsenol™ EG 18P, Nippon Gohsei, J) (PVA05 155 
and PVA18); glycerol, GLY (Pharmagel, I); caffeine, CFF (A.c.e.f, I, melting point 238 °C). 156 
 157 
2.2. Methods 158 
2.2.1 Preparation of PVA-based formulations 159 
Plasticized PVA formulations containing 15% by weight of GLY calculated on the dry polymer, 160 
indicated as PVA05GLY and PVA18GLY, were prepared by kneading. PVA powder, previously 161 
dried in an oven (40 °C for 24 h), was placed in a mortar and the liquid plasticizer was added dropwise 162 
under continuous mixing. The resulting mixture was oven dried at 40 °C for 8 h. Afterwards, 163 
aggregates were ground by means of a blade mill and the < 250 µm powder fraction was recovered. 164 
A tracer-containing formulation, indicated as PVA05GLY-CFF, was prepared immediately before 165 
processing by mixing in a mortar CFF powder, previously desiccated at 40 °C in an oven for 24 h, 166 
with PVA05GLY in a 1:9 weight ratio. 167 
 168 
 169 
 170 
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2.2.2 Manufacturing of PVA-based samples 171 
Specimens having different geometries were prepared by HME and FDM. Virtual models of the 172 
straight bar (I-shape), U-shaped and helix items designed are reported in Figure 1. 173 
 174 
 175 
Figure 1: virtual models with dimensional details of items having original I-, U- and helix-shapes. 176 
 177 
2.2.2.1 Extrusion 178 
HME was performed by a twin-screw extruder (Haake™ MiniLab II, Thermo Scientific, US-WI) 179 
equipped with counter-rotating screws. The material was extruded through a rectangular cross-section 180 
die (4 x 1 mm). In Table 1, the polymeric formulations and processing conditions are reported. Both 181 
were selected through a preliminary setup based on evaluation of the product quality (e.g. aspect, 182 
homogeneity, compliance with previously set size specifications and reproducibility), taking 183 
advantage of the experience previously acquired on hot-processing of PVA (Melocchi et al., 2015b, 184 
2016). Particularly, GLY was chosen as the plasticizer based on its widely reported use with PVA 185 
(Jang and Lee, 2003; Lin and Ku, 2008; Mohsin et al., 2011). 186 
I-shaped samples of 50 mm in length were obtained by cutting. U- and helix-shape items required 187 
manual post-processing. In the former case, the material coming out of the extruder was bent around 188 
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a stainless steel tool (ø = 15 mm) and then removed after 2 min of cooling. In the latter case, the 189 
extruded material was wrapped around a stainless steel tool (ø = 6 mm), purposely developed with a 190 
groove of the helix to be obtained (distance between adjacent turns = 5 mm), and then removed after 191 
the same cooling time. Immediately after production, I-, U- and helix-shaped samples were packed 192 
in heat seal alufoil moisture barrier bags. 193 
Filaments for FDM were prepared under analogous process conditions by extruding the same 194 
polymeric formulations through a custom-made aluminum circular die (ø = 1.80 mm), as reported in 195 
(Melocchi et al., 2016). Extruded rods were manually pulled and forced to pass through a caliper 196 
connected with the extruder and set at 1.80 mm. This was required to counteract possible swelling 197 
phenomena of the extruded rods and calibrate the relevant diameter, thus enhancing the yield of final 198 
product compliant with the specifications set, i.e. 1.75 ± 0.05 mm. After production and cooling, 199 
filament diameter was verified every 5 cm in length, and portions out of specifications were discarded. 200 
Indeed, filaments with diameter greater than 1.80 mm were unsuitable for printing. 201 
 202 
2.2.2.2 3D printing 203 
FDM was performed by a Kloner3D 240® Twin (Kloner3D, I) printer equipped with 0.4 mm nozzle 204 
(infill = 100%, layer height = 0.10 mm, printing speed = 23 mm/s, separation gap for raft and supports 205 
= 0.5 mm), using computer-aided design (CAD) files purposely developed. Items were designed using 206 
Autodesk® Autocad® 2016 software version 14.0 (Autodesk Inc., US-CA), saved in .stl format and 207 
imported to the 3D printer software (Simplify 3D, I). A further software (Netfab, I) was employed 208 
when the mesh number of the digital model needed to be increased, i.e. in the case of samples 209 
comprising curvatures. 210 
Portions 25 cm long of the in-house prepared filaments were used. Printing temperature was set as 211 
reported in Table 1. 212 
 213 
11 
Table 1: HME and FDM process conditions 214 
Material 
HME FDM 
T (°C) Screw speed (rpm) Torque (N·cm) T (°C) 
PVA05 200 100 190 200 
PVA05GLY 170 100 100 180 
PVA18GLY 200 100 220 n.d.* 
PVA05GLY-CFF 175 100 120 185 
*n.d. = not determined because of unfeasible manufacturing 215 
 216 
2.2.3 Thermo-mechanical characterization 217 
Samples cut from I-shaped items fabricated by HME and FDM, were subjected to differential 218 
scanning calorimetry (DSC) and dynamic-mechanical thermal analysis (DMTA). 219 
DSC analyses were performed by DSC Q100 (TA Instruments, US-DE; n = 1), using nitrogen as a 220 
purge gas (70 mL/min). Indium was used as a calibration standard. Samples of about 10 mg were 221 
heated in aluminum crucibles from -50 °C to 240 °C, maintained at this temperature for 1 min, cooled 222 
down to -50 °C and reheated up to 240 °C. Both heating and cooling steps were run at 10 °C/min. 223 
Additional DSC tests were carried out with wet samples, maintained in distilled water for 30 min, 224 
and equilibrated under ambient conditions overnight (final water content of about 8-10% evaluated 225 
by thermogravimetric analysis). 226 
DMTA tests were performed by a Q800 TA Instruments analyzer (TA Instruments, US-DE; n = 1), 227 
in displacement-controlled tensile mode, on ≈ 15 mm long specimens. The experiments were carried 228 
out at 1 Hz, with an applied displacement amplitude of 10 μm, from -50 °C to a maximum temperature 229 
equal to 100 °C / 120 °C, at a heating rate of 3 °C/min. 230 
 231 
2.2.4 Water-induced shape memory experiments 232 
The shape memory test consisted of two different phases, i) programming of the temporary shape and 233 
ii) recovery of the original shape (Figure 2). The programming step was performed as follows. 234 
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- Heating of the sample up to the deformation temperature (Tdef ≈ Tg + 35 °C, where Tg indicates the 235 
material glass transition temperature measured by DSC). 236 
- Deformation, by means of specially designed tools, of the sample maintained at Tdef. Samples having 237 
original U- or helix-shape were deformed to take on programmed temporary I-shape. Conversely, I-238 
shaped samples were deformed to take on programmed temporary U-shape. 239 
- Cooling of the sample in the fixed temporary shape below Tg. In case of plasticized PVAs, showing 240 
relatively low Tg, after deformation the samples were kept in a freezer at -20 °C in order to avoid 241 
early recovery. 242 
Recovery of the original shape was obtained following immersion of the deformed samples into 100 243 
mL of unstirred distilled water. The experiment was carried out both at room temperature and at 37 244 
± 0.5 °C, by using a thermoregulated bath. The recovery process was monitored using digital cameras 245 
(n = 1, Nikon D700 18-105 VR Kit, AF-S DX NIKKOR 18-105 mm f/3.5-5.6G ED VR, J and GoPro 246 
Hero Session, US-CA). 247 
In case of originally I- or U- shaped samples, photographs acquired were processed by means of a 248 
specific software (ImageJ, US-MD) to measure the variation of the angle between the two arms (α) 249 
occurring during the recovery. Recovery index (RI) versus time curves were then built, with RI 250 
calculated as follows: 251 
- for specimens with original I-shape 252 
RI =  
α−αp
π−αp
   Eq. (1) 253 
- for specimens with original U-shape 254 
RI =  1 −  
α
αp
   Eq. (2) 255 
where αp is the angle obtained in the programming phase (angles in rad). 256 
The time (tRIfinal) to reach final RI (RIfinal), i.e. the RI value calculated based on measurement after 257 
which no more changes in α were observed, was also recorded. 258 
For specimens with original helix-shape, only the RIfinal was considered, being calculated as follows: 259 
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RIfinal =  
Nfin
N0
  Eq. (3) 260 
where Nfinal and N0 represent the number of windings at the end of recovery and before programming, 261 
respectively. 262 
 263 
 264 
Figure 2: outline of the experiments performed to evaluate the water-induced shape memory 265 
response. 266 
 267 
2.2.5 Evaluation of fluid uptake and residual dry mass 268 
Extruded and printed samples having original I-shape (n = 3) were characterized in terms of fluid 269 
uptake and residual dry mass over 4 h of immersion in unstirred simulated urine fluid (400 mL) kept 270 
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at 37 ± 0.5 °C prepared as indicated in (Sherif et al., 2018). Each specimen was laid on a stainless 271 
steel net (w = 2.5 cm, h = 7 cm, mesh = 1.5 mm) before immersion and then withdrawn after 272 
predetermined time periods, gently blotted and weighed. Final dry masses were also determined after 273 
maintaining samples in an oven at 40 °C for 24 h. Two parameters were calculated, the percentage 274 
fluid uptake (FU) and the percentage residual dry mass (RDM), according to the following equations: 275 
𝐹𝑈(%) = [
(𝑊𝑚−𝑊𝑑)
𝑊𝑚
] × 100   Eq. (4) 276 
where Wm is the mass of the wet sample on withdrawal and Wd is the mass of the sample after drying; 277 
 278 
𝑅𝐷𝑀(%) = 1 −  [
(𝑊𝑖−𝑊𝑑)
𝑊𝑖
] × 100  Eq. (5) 279 
where Wi is the initial mass of the sample. 280 
 281 
2.2.6 Evaluation of release performance 282 
Tracer-containing extruded and printed samples were tested for release using a USP38 dissolution 283 
apparatus 2 (10 rpm, 37 ± 0.5 °C; Distek, CH; n = 3). 400 mL of simulated urinary fluid were used 284 
as the dissolution medium. Fluid samples were withdrawn at specific time points and assayed 285 
spectrophotometrically (λ = 206 nm). By linear interpolation of the release data immediately before 286 
and after the time point of interest, times to 10% and 90% release (t10% and t90%, respectively) were 287 
calculated. 288 
During the release test, photographs of samples were taken every 5 s (GoPro Hero Session, US-CA). 289 
 290 
3. Results and Discussion 291 
The temporary shape of a retentive intravesical delivery system should be such as to allow 292 
administration through a catheter without any constraints (e.g. straight bars with limited diameter and 293 
indefinite length). On the other hand, recovery of the original shape, designed to promote retention 294 
within the bladder for a pre-determined period of time (from few hours up to several days) without 295 
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damaging its walls, should spontaneously take place in situ as a result of interaction with biological 296 
fluids. If water soluble SMPs are chosen as main components of the delivery system, no invasive 297 
procedure would ultimately be needed for the relevant removal. 298 
 299 
3.1 Design and fabrication of specimens 300 
The experimental work was aimed at attaining specimens showing water-induced shape shifting 301 
phenomena representative of each stage of performance for the retentive intravesical delivery 302 
platform proposed. For this purpose, hot-processing techniques, namely HME and FDM, were 303 
employed. FDM has recently been demonstrated to be a versatile manufacturing process for 304 
fabrication of drug delivery systems having complex geometries and composition, such as orally 305 
administered dosage forms (e.g. tablets, matrices, capsules, hollow and multilayer systems), implants 306 
and inserts (Genina et al, 2017, Goole and Amighi, 2016, Goyanes et al., 2015, Maroni et al., 2017, 307 
Melocchi et al., 2015a, 2018, Okwuosa et al., 2017, Sandler and Preis, 2016, Tagami et al., 2018, 308 
Zema et al, 2016). In the particular field of intravesical delivery, which FDM has not been applied to 309 
so far, this 3D printing technique would grant the possibility of personalizing the pharmacological 310 
therapy in terms of type and dose of conveyed drugs, possible co-administration scheme (fixed drug 311 
combinations or extemporary compositions), and achievable release kinetics. With regard to HME, 312 
not only would it be viable for the device fabrication, but also is necessarily associated with FDM 313 
processing as it provides the filaments required for printer feeding. 314 
Among polymers exhibiting water-induced shape memory response and good hot-processability, 315 
swellable/erodible ones, able to interact with aqueous fluids ultimately dissolving/eroding, appeared 316 
especially advantageous as main components for the delivery system. Indeed, such materials undergo 317 
a glass-rubber transition when in contact with biological fluids with formation of a gel, the 318 
dissolution/erosion behavior of which depends on the relevant viscosity and, therefore, on the 319 
polymer molecular weight. Particularly, PVA was selected based on both the experience gained on 320 
relevant processing via HME and FDM as well as the review of preliminary literature findings on the 321 
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exhibited water-driven shape memory ability, which relies on its semi-crystalline nature or may be 322 
obtained by crosslinking (De Jaeghere et al., 2015, Fang et al., 2017, Melocchi et al., 2015b, 2016, 323 
Qi et al., 2014). With respect to SMPs already proposed for drug delivery purposes, mainly including 324 
newly synthetized crosslinked polymers wanting regulatory approval, the PVA selected offers the 325 
advantage of a long-established use and safety profile (Nagahama et al., 2009, Neffe et al., 2009, 326 
Wischke et al, 2009, Wischke and Lendlein 2010). In addition, being available in different molecular 327 
weights, it was expected to be a versatile material that would allow for a range of diversified release 328 
rates of the active ingredient conveyed and bladder retention times of the system. 329 
Different molecular weights of PVAs, either unplasticized or in admixture with a plasticizer and/or 330 
tracer, were used. In order to broaden the scope of information achievable in terms of process and 331 
performance, the specimens based on these formulations were conceived in three geometries, having 332 
different extent of complexity, either mimicking the original (i.e. enabling bladder retention) or the 333 
temporary (i.e. enabling administration) shape of the device: a U-shaped item, a helix, as a possible 334 
evolution of the U-shape, and a simple straight bar (I-shape). The latter shape was chosen as a 335 
prototypical screening tool on account of the expected ease of fabrication, while the helix shape was 336 
considered of particular interest in view of intravesical application as it combines several advantages 337 
and a rather simple design. As compared with the U-shape, helical geometry could not only take on 338 
a temporary bar-like shape suitable for administration and then recover the original retentive 339 
configuration, but also be expected to have improved bladder retention, thanks to their numerous 340 
windings, and enhanced patient compliance. Indeed, a helix might behave like a spring that undergoes 341 
compression from resting position and shortens its natural length, thereby withstanding possible 342 
mechanical stresses, deriving from muscle contraction during urination, and limiting discomfort. If 343 
further improvement of the helical geometry were pursued, the presence of any sharp tip might be 344 
overcome to reduce the potential for damaging the urothelium. 345 
Originally I-, U- and helix-shaped samples were fabricated by FDM starting from in-house extruded 346 
filaments. Specimens having such designs were also fabricated by HME for comparison purposes and 347 
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were thus used as a reference to design the virtual models for FDM. By way of example, Figure 3 348 
shows photographs of the extruded and printed samples based on plasticized PVA05. Notably, 349 
materials being extruded have to undergo bending and coiling before cooling to reach final original 350 
shapes other than straight ones, thus involving purposely-developed tools and attentive process 351 
design. Conversely, items having relatively complex geometries (e.g. U- and helix-shape) could 352 
directly be fabricated by 3D printing. Revision of CAD files was needed to counteract possible 353 
expansion phenomena encountered with the polymeric formulations in use following preliminary 354 
printing trials. Indeed, by calculating a correction coefficient, as described in (Melocchi et al, 2015a), 355 
printed items matching the dimensions of those prepared by HME were obtained. In addition, for 356 
samples comprising curvatures (i.e. originally U-shaped and helix-shaped specimens), the mesh 357 
number, i.e. a collection of vertices, edges and faces used to describe the shape of a tridimensional 358 
object, had to be increased in the virtual model in order to improve the resolution thus obtaining a 359 
smoother surface. FDM was performed by means of a 3D printer characterized by two arms working 360 
independently, which enabled contemporaneous fabrication of different parts thus reducing the 361 
overall printing time. The presence of a fixed build plate allowed to overcome manual calibration 362 
issues and also limited the exposure of the object in fabrication to uncontrolled airflow, known to 363 
hinder uniform cooling thereby impacting on product mechanical properties (e.g. reduced stiffness, 364 
layer detachment in the area subjected to greater cooling). Items were fabricated in the presence of a 365 
raft, because this turned out to increase adhesion of first printed layers to the build plate. Printing of 366 
helix-shaped items also required the use of supports between each winding to avoid collapsing during 367 
vertical growth. A separation gap of 0.5 mm was set between the object and the raft as well as supports 368 
to make them easily removable without damage. Printing speed was kept low (23 mm/s) to enhance 369 
accuracy and avoid dragging of latest layered material, which may cause detachment of the item in 370 
fabrication from the build plate. Under these conditions, PVA05-based formulations were 371 
successfully printed without technical issues at temperatures established on the basis of their thermal 372 
behavior. As expected, the presence of the plasticizer resulted in improved printing and reduced 373 
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number of failures. Notably, the obtained helical-samples, subjected to manual compression, were 374 
shown to behave like a spring, i.e. shorten in length when stressed and then return to the initial 375 
position after stress removal. In spite of the overall actions taken to make the process feasible, it was 376 
not possible to print any item starting from PVA18, either unplasticized or in admixture with GLY. 377 
Indeed, because the pressure needed for material extrusion during the 3D process is only exerted by 378 
the mass of the filament being loaded, the melt viscosity of such polymer was too high to enable its 379 
flow through the available nozzle. While increasing the printing temperature was expected to reduce 380 
the polymer viscosity, such an adjustment turned out not to be viable as browning of the material was 381 
observed. On the other hand, HME was successfully carried out with all the PVA formulations under 382 
investigation, except for PVA18 in the absence of plasticizer because torque values exceeding the 383 
maximum allowed by the equipment in use would have been needed. 384 
 385 
 386 
Figure 3: photographs of originally I-, U- and helix-shaped specimens based on PVA05GLY 387 
obtained by a) HME and b) FDM. 388 
 389 
3.2 Shape memory response 390 
A basic experimental screening was carried out on I-shaped specimens obtained by HME and FDM 391 
in order to determine how the thermo-mechanical properties of samples may lead to their shape 392 
memory. In particular, as the temperature required to activate the shape transformation strictly 393 
depends on the material glass transition temperature, DSC analyses were initially performed. Indeed, 394 
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shape shifting phenomena depend on amorphous regions of the polymer gaining mobility when Tg is 395 
reached, while permanent shape could be supported by crystalline domains, which would undergo 396 
melting at a higher temperature thus acting as net points (Fang et al, 2017). Therefore, evaluating 397 
how Tg is affected by the polymer grade, the presence of plasticizer and the interaction with water is 398 
of utmost importance because the temporary shape i) must be programmed at Tdef > Tg (in the present 399 
case Tdef ≈ Tg + 35 °C), ii) can be preserved keeping the material at T < Tg and iii) is reversed to the 400 
original shape at T > Tg. In this specific case, shape recovery phenomena should take place at 37 °C. 401 
Because shape recovery is activated at temperatures above Tg, any change in such a property is 402 
expected to be highlighted in the shape memory experiments. By DMTA, the evolution of material 403 
stiffness was described, and in particular storage modulus was measured below room temperature 404 
(Troom) and at Tdef, corresponding to sample stiffness before and after recovery, respectively. 405 
 406 
3.2.1 DSC experiments 407 
DSC thermograms are reported in Figure 4, choosing the second scan since it provided Tg values 408 
similar to those of the first one but easier to read. These curves displayed a regular shape, i.e. a well-409 
defined inflection point corresponding to the material Tg, and no other exo-/endo-thermal signals. Tg 410 
values obtained from these thermograms are reported in Table 2: minor differences in Tg measured 411 
for extruded and printed specimens were observed. 412 
The plasticization effect of GLY turned out evident for PVA05, as a decrease of 37 °C and 46 °C in 413 
Tg was noticed with PVA05GLY-based samples obtained by HME and FDM, respectively. Such an 414 
effect was attributed to the ability of the plasticizer to modify the 3D organization of the polymer 415 
matrix (Mohsin et al., 2011). In fact, due to its low-molecular weight and hydroxyl groups, GLY is 416 
known to lead to the formation of polymer-plasticizer hydrogen bonds to the detriment of interactions 417 
among polymer chains, thus reducing the intermolecular attraction forces and increasing the 418 
macromolecule mobility at temperatures below those at which the neat polymer undergoes transition. 419 
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In the case of wet samples, it was evident that also water taken up acted as a plasticizer for PVA, 420 
reasonably by weakening intra- and inter-molecular hydrogen bonds and increasing mobility of 421 
macromolecular chains (Figure 4a, Table 2). Indeed, progressive water absorption is known to 422 
concomitantly induce a decrease in the polymer Tg below room temperature until an equilibrium is 423 
reached. Particularly, the most marked decrease was recorded in the case of the wet as compared with 424 
dry PVA05 sample. The observed plasticization effect of water, allowing macromolecules to gain 425 
mobility, would enable activation of the shape shifting process at room temperature and below, which 426 
is the basis for the water-induced shape memory response. 427 
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 428 
Figure 4: DSC thermograms (in the Tg region) from originally I-shaped specimens obtained by a) 429 
HME and b) FDM. Dotted vertical bars indicate Tg. 430 
 431 
 432 
 433 
 434 
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Table 2: Tg from DSC analyses, for originally I-shaped specimens obtained by HME and FDM. 435 
Data in brackets refer to wet samples 436 
 437 
 
Tg (°C) 
HME FDM 
PVA05 60 (10) 57 
PVA05GLY 23 (-11) 11 
PVA18GLY 27 (4) n.a.* 
* n.a. = non-available sample because of unfeasible manufacturing 438 
 439 
3.2.2 DMTA experiments 440 
Figure 5 shows the storage modulus (E') vs temperature curves obtained from extruded and printed 441 
specimens subjected to DMTA. 442 
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 443 
Figure 5: E' vs temperature curves from originally I-shaped specimens obtained by a) HME and b) 444 
FDM. 445 
 446 
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The plasticization effect induced by GLY, previously observed in DSC thermograms, was confirmed 447 
by DMTA data. Indeed, the reduced extent of interaction among PVA chains brought about by the 448 
addition of plasticizer resulted in a decrease in the sample stiffness, irrespective of the manufacturing 449 
technique considered. A decrease in Tg for GLY-containing specimens was confirmed by shifting of 450 
E' curves towards lower temperatures. E' traces also provided an indication of the stiffness of the 451 
material below and across the transition region. Table 3 reports E' values determined both at room 452 
temperature (E'Troom) and at Tdef (E'Tdef), at which the material showed a rubbery behavior, as well as 453 
the relevant percentage difference (ΔE'), defined as: 454 
∆E′(%) =
ETroom
′ −ETdef
′
ETroom
′  ×  100  Eq. (6) 455 
These values were chosen since E'Troom would be representative of the stiffness of samples in their 456 
original shape, E'Tdef would be an estimation of such a characteristic right after the shape memory 457 
transition, while ΔE' would represent the overall stiffness change during the transition. E'Tdef and ΔE' 458 
may overestimate and underestimate, respectively, stiffness and overall change in stiffness, since it 459 
is known that water absorption, and eventually polymer dissolution, would lead to a relevant decrease. 460 
 461 
Table 3: E'Troom, E'Tdef and ΔE' from originally I-shaped specimens obtained by HME and FDM 462 
 463 
 E'Troom (MPa) E'Tdef (MPa) ΔE' (%) 
HME FDM HME FDM HME FDM 
PVA05 4060 4330 440 410 89 90 
PVA05GLY 830 2750 70 120 92 96 
PVA18GLY 1420 n.a.* 80 n.a.* 94 n.a.* 
* n.a. = non-available sample because of unfeasible manufacturing 464 
 465 
Irrespective of the manufacturing technique employed, PVA05 specimens displayed a stiff behavior 466 
at Troom, the storage modulus decreasing of one order of magnitude at Tdef with an overall stiffness 467 
change of about 90%. Not only the PVA05GLY but also PVA18GLY samples exhibited, because of 468 
the presence of GLY, lower E'Troom and E'Tdef, and a slightly higher overall variation (92-96%). The 469 
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higher stiffness shown at Troom by printed specimens with respect to extruded ones might be ascribed 470 
to processing. 471 
In general, the drop of E' indicates the occurrence of a relaxation process that, for these materials, 472 
could be ascribed to glass transition of PVA (Chartoff et al, 2009). In support of the DSC data, Tg 473 
was also evaluated by DMTA, confirming minor differences, associated with the technique employed 474 
for sample manufacturing, as observed by DSC. Indeed, for a given material and specimen 475 
preparation method, a difference between transition temperatures determined by DSC and by DMTA, 476 
with the latter being systematically higher than the former, is expected and intrinsically related to the 477 
differences between the two experimental techniques and corresponding testing parameters, such as 478 
heating rate and frequency. Because transition temperatures coming from DMTA exhibit testing 479 
frequency dependence, Tg values obtained by DSC were used for assessment of Tdef in the shape 480 
memory experiments.  481 
 482 
3.2.3 Shape recovery experiments 483 
The water-induced shape recovery process was studied in unstirred distilled water at room 484 
temperature, by monitoring evolution of the shape of extruded and printed samples from the 485 
temporary one. By analyzing photographs taken at successive time points, RI was calculated to 486 
describe the shape recovery process. By way of example, images of printed PVA05GLY specimens 487 
having different original shapes are collected in Table 4. 488 
 489 
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Table 4: photographs acquired during shape recovery experiments (room temperature) of PVA05GLY specimens having original I- and U-shape 490 
obtained by FDM. A solid line is superimposed to highlight the recovery process 491 
 492 
 
      
 
 
 
 
 
 
 
109 min 
 
      
original shape temporary shape 1 min 10 min 30 min 60 min 120 min 
 493 
10 mm 10 mm 
10 mm 
10 mm 
10 mm 
10 mm 
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The recovery ability observed for a very simple original shape (i.e. I-shaped specimen programmed 494 
to take on temporary U-shape) was also shown by samples having an original U-shape (programmed 495 
to take on temporary I-shape) and comparable recovery times were found in both cases, irrespective 496 
of geometry. A shape-shifting effect similar to that exhibited by printed PVA05GLY samples was 497 
observed for the other formulations examined. An almost full recovery of the original shape was 498 
obtained from specimens having all geometries under investigation. The recovery process was also 499 
monitored over time and α was measured at successive time points to calculate the corresponding RI 500 
values. Recovery curves from selected extruded and printed samples with different original shapes 501 
are reported in Figure 6. With PVA05 samples, determination of RI in the final stage of the recovery 502 
process was impaired by concurrent polymer dissolution causing distortion of the specimens, which 503 
impaired the assessment of their shape evolution. In such cases, measurements had to be interrupted, 504 
and this was highlighted in the curves by marking the last RI value acquired. 505 
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 506 
Figure 6: RI vs time curves from a) originally I-shaped specimens of all compositions obtained by 507 
HME and b) originally I- and U-shaped PVA05-based specimens obtained by FDM, tested at room 508 
temperature (x indicates the last datum acquired before measurements were impaired by the 509 
polymer dissolving). 510 
 511 
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For samples manufactured by HME, the addition of GLY to PVA05 modified the recovery process 512 
kinetics (Figure 6a). This is consistent with previous reports showing the effect of plasticizer on the 513 
shape memory response of semi-crystalline polymers (Cai et al., 2017). With unplasticized PVA05, 514 
recovery showed an initial induction phase followed by a high rate phase (about 120 min long). By 515 
contrast, with PVA05GLY the process started with a high rate without any induction phase and the 516 
overall duration of recovery was reduced. These differences may be related to the fact that for 517 
PVA05GLY, having Tg below the recovery test temperature, the recovery process would be a 518 
combination of water- and temperature-induced shape memory effects, whereas for the unplasticized 519 
polymer, having Tg above the test temperature of approximately 30 ° C, recovery would result from 520 
water-induced shape memory only. Moreover, because of the greater free volume associated with the 521 
lower Tg, water diffusion phenomenon may be faster with the plasticized polymer, thus resulting in a 522 
faster activation of the shape memory effect. As regards PVA18, HME was feasible with the 523 
formulation containing GLY only, and the resulting sample exhibited a similar recovery pattern as 524 
compared with the PVA05GLY one, although the rate of the process was lower after the first few 525 
minutes of testing. The influence of molecular weight of the polymer on the relevant shape shifting 526 
phenomena would deserve further investigation, also considering literature findings mainly focused 527 
on its impact on recovery index (Chen et al., 2007, Petisco-Ferrero et al., 2016). 528 
In Figure 6b, it can be observed that the recovery curve of the printed PVA05 specimen showed an 529 
analogous induction phase, of approximately 2 h, with respect to the extruded sample having the same 530 
composition. However, the recovery rate in the subsequent phase turned out higher for the specimen 531 
obtained by FDM. The printed vs extruded PVA05GLY specimens were characterized by much faster 532 
initial recovery followed by a decrease in the process rate after some minutes from the beginning of 533 
the test, regardless of their original shape. Such differences in the initial recovery rate might be related 534 
to the different surface porosity/roughness of specimens fabricated by HME and FDM. Although 535 
specimens of comparable dimensions were prepared by the two techniques, the effective 536 
surface/volume ratio that governs water absorption kinetics is likely to be higher for printed than 537 
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extruded specimens due to a more porous structure resulting from the additive manufacturing process. 538 
The subsequent decrease in recovery rate of printed items, together with a less marked difference in 539 
the time needed for complete recovery observed with plasticized vs unplasticized samples, may be 540 
suggestive of the inherent layered nature, which would be brought out by the contact with water. It 541 
could be hypothesized that the various layers may not swell jointly following progressive water 542 
penetration. By contrast, extruded items would most likely be expected to behave as a continuous 543 
matrix. However, such an aspect is little known and is worth being explored, because in-depth studies 544 
comparing the water-induced shape memory response of extruded and printed items have not been 545 
reported in the scientific literature. An investigation into the possible differences in the temperature-546 
induced shape memory behavior of items obtained starting from poly(ethylene-co-methacrylic acid) 547 
either by FDM or compression molding, a technique well-known for producing non-porous items, 548 
has so far been reported (Zhao et al., 2017). 549 
Recovery studies were also carried out under body temperature conditions. Table 5 summarizes RIfinal 550 
values obtained and corresponding tRIfinal, collected at room temperature and 37 °C from extruded and 551 
printed specimens having original I-shape. 552 
 553 
Table 5: RIfinal values and corresponding tRIfinal from specimens having original I-shape tested at 554 
room temperature and 37 °C 555 
 
Room temperature 37 °C 
RIfinal tRIfinal (min) RIfinal tRIfinal (min) 
HME 
PVA05 0.93a 251a 0.97 146 
PVA05GLY 0.99 100 0.86 28 
PVA18GLY 0.99a 90a 0.92a 55a 
FDM 
PVA05 0.82a 180a n.d. n.d. 
PVA05GLY 0.97 109 0.88a 26a 
a determination hindered by dissolving of the polymer with possible distortion of the 556 
specimen 557 
n.d. = not determined because of pronounced distortion of the specimen 558 
 559 
Generally high RIfinal was shown by both extruded and printed specimens, with lower values for 560 
PVA05-based formulations. Because shape recovery and polymer dissolution occur concomitantly, 561 
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RIfinal could hardly be determined when the rate of shape recovery was lower than that of dissolution, 562 
thus leading to considerably reduced size or changes in consistency of the sample. In the case of the 563 
printed PVA05 specimen, it was not even possible to determine RIfinal because of dissolution-driven 564 
distortion that was ascribed to the reduced gel viscosity and sample stiffness due to the high extent of 565 
hydration reached, close to the dissolution threshold. At both temperatures, the presence of GLY 566 
accelerated the recovery process, with up to a four-fold decrease in tRIfinal at 37 °C for PVA05GLY 567 
specimens. Because the Tg was by far lower than the test temperature, such a marked acceleration of 568 
recovery may have resulted from a combination of water- and temperature-induced shape memory 569 
effects. A reduction of tRIfinal was observed for all formulations tested at 37 °C as compared with room 570 
temperature, with extent of reduction of tRIfinal consistent with that of Tg values, as could be expected 571 
based on the increased mobility of the amorphous PVA domains. In the case of extruded specimens 572 
containing plasticizer (PVA05GLY and PVA18GLY), the time needed for recovery turned out to be 573 
affected by the polymer molecular weight at 37 °C. 574 
The overall results confirmed that the use of originally straight bar-shaped samples as a screening 575 
tool could be appropriate, and the information gathered may profitably be exploited in the design of 576 
devices with more complex geometries 577 
 578 
3.3 Fluid uptake and residual dry mass 579 
Because thermo-mechanical properties and recovery of the original shape of samples was 580 
demonstrated to be affected not only by temperature but also by their exposure to aqueous media, it 581 
was deemed interesting to investigate the kinetics of biological fluid uptake. Concomitantly, the mass 582 
loss behavior of the same specimens was studied over time. Indeed, the overall bladder retention time 583 
of the device, the onset and time frame of shape shifting phenomena as well as its ability to control 584 
the release of the conveyed drug would be related to the rate and extent of hydration and 585 
erosion/dissolution of the polymeric formulation. 586 
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Extruded and printed specimens having original I-shape were thus evaluated for FU and RDM, 587 
employing simulated urinary fluid kept at 37 ± 0.5 °C to mimic the environment in which the system 588 
was supposed to perform. 589 
From FU and RDM profiles, reported in Figure 7, it turned out evident that the rate of fluid uptake 590 
was by far higher than that of mass loss. Indeed, approximately 40% of fluid taken up was reached 591 
within the first 15 min of testing, irrespective of the formulation and manufacturing technique 592 
considered. In the case of extruded items, the rate of mass loss of PVA05GLY was greater than that 593 
of PVA18GLY specimens. This could be explained on the basis of the different molecular weights 594 
of the employed polymer, which is known to be associated with viscosity of the hydrated matrix thus 595 
affecting the relevant rate of erosion/dissolution. The addition of GLY to PVA05 slightly accelerated 596 
the initial fluid uptake, which was evident especially in the case of extruded samples reasonably due 597 
to their less porous structure that could have hindered penetration of the aqueous medium. Because 598 
of pronounced hygroscopicity, the plasticizer may have increased water affinity of specimens, thus 599 
favoring absorption of the aqueous fluid (Mohsin et al., 2011). Indeed, the hydroxyl groups of GLY 600 
would be able to establish hydrogen bonds with both water and polymer, thus increasing the 601 
molecular mobility of the latter and the free volume in the samples. In the case of PVA05, the 602 
threshold absorbed amount of aqueous medium needed for sufficient mobility of the polymer chains 603 
to be acquired and dissolution to take place was therefore higher than with the plasticized formulation. 604 
Interestingly, the fluid uptake behavior of the specimens was consistent with the shape recovery 605 
previously discussed. As expected, activation of shape shifting phenomena in GLY-containing 606 
samples was especially rapid because the polymer Tg was not only decreased by the presence of 607 
plasticizer but also by the relatively high extent of fluid taken up in the first minutes of testing. 608 
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 609 
Figure 7: average FU (solid lines) and RDM (dashed lines) curves from originally I-shaped 610 
specimens obtained by a) HME and b) FDM. 611 
 612 
3.4 Evaluation of tracer-containing specimens 613 
The potential of the PVA-based formulations under investigation for slowly releasing an active 614 
ingredient while undergoing prompt shape modifications was preliminarily evaluated using 615 
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specimens containing CFF as an analytical tracer. Specimens having original I-shape were initially 616 
characterized for thermo-mechanical properties. A further decrease in Tg was found with respect to 617 
the corresponding samples devoid of CFF (Tg = 1 °C vs Tg = -3 °C for extruded vs printed items), 618 
which was already observed with a different thermoplastic polymer (Burgess et al., 2015). Moreover, 619 
the printed and extruded tracer-containing specimens showed comparable stiffness at Troom while 620 
higher values of E'Tdef, thus resulting in an overall stiffness reduction of about 70% (E'Troom = 1110 621 
MPa vs E'Troom = 1010 MPa and E'Tdef = 340 vs E'Tdef = 280 MPa for extruded vs printed items). 622 
Samples having different original shapes, fabricated via both techniques, showed the ability to 623 
undergo shape recovery induced by water at room temperature and 37 °C, regardless of the presence 624 
of CFF (Table 6 and 7). With originally I-shaped samples, recovery turned out faster with respect to 625 
the previously tested ones, which was consistent with the Tg values relevant to the PVA05GLY-CFF 626 
formulation. In spite of a comparable extent of recovery, tRIfinal was nearly doubled for the extruded 627 
specimen as compared with the printed one. This was in agreement with the findings obtained from 628 
tracer-free specimens and is not surprising on account of the layered nature of items attained by 629 
additive manufacturing. 630 
 631 
Table 6: RIfinal values and corresponding tRIfinal from specimens having original I- and helix-shape 632 
tested at room temperature 633 
 Original shape RIfinal tRIfinal (min) 
HME 
I-shape  0.94 40 
helix-shape  0.75 26 
FDM 
I-shape  0.76a  12a  
helix-shape 0.71 12 
a determination hindered by dissolving of the polymer with possible distortion 634 
of the specimen 635 
35 
Table 7: photographs acquired during shape recovery experiments (37 °C) of PVA05GLY-CFF specimens having original helix shape, obtained by 636 
HME and FDM, programmed to take on a temporary I-shape. A solid line is superimposed to highlight the recovery process 637 
H
M
E
 
      
F
D
M
 
      
 
original shape 1 min 5 min 10 min 15 min 30 min 
 638 
10 mm 
10 mm 
36 
Release of the tracer from extruded and printed samples having original I-shape was studied after 639 
programming and fixing of the temporary U-shape, in order to evaluate the performance during 640 
recovery (Figure 8a). For this purpose, photographs of specimens were collected throughout the 641 
release test, and selected images relevant to printed items are reported in Figure 8b by way of 642 
example. 643 
 644 
 645 
Figure 8: a) release profiles from originally I-shaped PVA05GLY-CFF specimens obtained by 646 
HME and FDM following programming and fixing of the temporary U-shape and b) photographs of 647 
the printed specimen at successive time points during the test. A solid line is superimposed to 648 
highlight the recovery process. 649 
37 
Release curves from extruded and printed specimens were almost superimposed. The release started 650 
without any lag phase and was completed within 2 h. Notably, with both extruded and printed 651 
specimens, the original straight shape was almost fully recovered before t10%, the most marked 652 
changes occurring within 60 s. 653 
 654 
Conclusions 655 
Indwelling drug delivery systems could be highly beneficial in the treatment of bladder diseases by 656 
increasing the intravesical residence time of drugs and compensating for the relevant washout. Such 657 
systems would thereby overcome failures and discomfort connected with repeated instillations 658 
through catheters. Moreover, they would allow different release kinetics to be established. The use of 659 
SMPs, in view of their ability to take on a programmed/temporary shape and recover the 660 
permanent/original one in the presence of an external stimulus, was regarded as an innovative strategy 661 
to develop retentive drug delivery systems with convenient administration mode. Among 662 
swellable/erodible SMPs characterized by water-induced shape memory response and good melt-663 
processability, PVA of pharmaceutical-grade was selected for design and fabrication via hot-664 
processing techniques, namely FDM 3D printing and HME, of an indwelling device for intravesical 665 
drug administration involving no removal procedure. In this respect, application of a 3D printing 666 
technique to an SMP would notably provide the basis for 4D printing because of the programmed 667 
changes in shape of the printed item occurring over time. 668 
Starting from formulations based on PVA of different molecular weights, specimens having diverse 669 
original shapes and compositions were successfully extruded and printed. After programming and 670 
fixing of a temporary shape, these exhibited the desired ability to recover the original one following 671 
interaction with aqueous fluids, and the overall recovery as well as its rate were consistent with those 672 
expected according to the thermo-mechanical properties of the investigated materials. The recovery 673 
process was relatively fast, particularly at 37 °C, which was considered potentially advantageous in 674 
the prospect of achieving prompt retention of the final system immediately after insertion into the 675 
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bladder. The softening upon glass-rubber transition of the polymer would impart favorable hardness 676 
characteristics to the device, such that limited mechanical impact on the bladder epithelium could be 677 
ensured. Purposely fabricated samples containing an analytical tracer turned out able to modify the 678 
release of the latter before complete dissolution, yielding prolonged release patterns consistent with 679 
the molecular weight of PVA employed. Thus, multi-functionality of the PVA-based materials 680 
investigated was highlighted, entailing water-induced shape shifting, controlled release of a tracer 681 
and erosion/dissolution in biological fluids. More extended and varied release profiles, associated 682 
with diversified retention times, could be pursued by appropriate formulation and processing choices, 683 
such as selection and combination of polymers having higher molecular weights, modulation of the 684 
amount of plasticizer, addition of release modifiers and improvement of the equipment to ease 685 
processing. 686 
Although preliminary in scope, this study pointed out the viability of the proposed approach based 687 
on hot-processing of a pharmaceutical-grade polymer having water-induced shape memory response 688 
in the manufacturing of retentive intravesical delivery systems, opening up new perspectives in 689 
application of 4D printing to the pharmaceutical field. 690 
  691 
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